White City companies recognised in MedCity’s Life Sciences Companies to Watch 2025
Fifteen companies from the White City Innovation District have been named in MedCity’s new Life Sciences Companies to Watch 2025 report, released to coincide with London Life Sciences Week. The annual snapshot highlights more than 60 emerging businesses across biotech, medtech and healthtech, and this year White City and the wider WestTech London community feature strongly.
The companies recognised include Autolus Therapeutics, Epsilogen, Micrographia Bio, MiNA Therapeutics, Orchard Therapeutics, Quell Therapeutics and Vivan Therapeutics, along with several newer ventures and university spinouts. Their work spans gene therapy, precision medicine, diagnostics and new cell engineering techniques. Together they show how rapidly White City’s innovation ecosystem is maturing and how firmly it is now embedded within the wider WestTech London cluster.
MedCity compiled the list through consultation with London’s universities, sector specialists and independent data platforms. An expert panel then refined a longlist of 120 companies to the final selection of 60. The report aims to give a clearer sense of the talent, ideas and technologies shaping the next generation of life sciences innovation across the capital.
Read more Read more about White City companies recognised in MedCity’s Life Sciences Companies to Watch 2025
